Please login to the form below

Not currently logged in
Email:
Password:

Ariana Pharma appoints Mariana Kuras as chief technology officer

She previously worked at Biosystems International and Pfizer

Ariana Pharma has appointed former Pfizer scientist Marian Kuras as the company's chief technology officer.

She will lead technological efforts at the French firm, which provides clinical data analysis services to pharma companies to identify best patient responders, identify patients at risk of adverse events and to remove bias from trials.

Prior to joining Ariana, Dr Kuras spent eight years at French biotech Biosystems International, including four as director of research.

During this period, she was responsible for the development and validation of biomarker platform technologies in several projects across therapy areas that included oncology and neurodegenerative diseases.

Previously, she was a genomics and bioinformatics scientist at Pfizer Global Research and Development in France.

Dr Kuras has serving as an independent scientific expert for the sixth and seventh framework of the European Commission.

"Ariana has become one of the most promising international players in diagnostic and personalised medicine," said Dr Kuras. "By providing a validated solution to the challenge of combining heterogenous data from multiple sources with patient characteristics, Ariana will continue to grow as industry demand continues to increase and I am looking forward to adding my experience to the Ariana effort."

24th August 2012

Share

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Medscape Medical Affairs

Medscape Medical Affairs enables all medical affairs professionals to take a more strategic leadership role, and maximize the impact of...

Latest intelligence

Tree
Pharma’s vital role in sustainability and corporate social responsibility
Pharma is in the spotlight as tough questions about sustainability commitments continue to arise...
Infographic: Therapy Watch Hyperlipidaemia
Our latest infographic offers an introduction to the real-world insights collected by our Hyperlipidaemia study....
Article: The rise of the healthcare influencer
In our latest article for Pharmaphorum Deep Dive, we explore the opportunities and benefits for healthcare companies in the online influencer space....